ADVANCED BIODEVICES LLC

Medtech

Nanofiber-based aqueous cleaning composition that flows through endoscope channels to remove biofilm and bacteria

novaflux.com →
Grants
$6.6M
6 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Improved cleaning technology for reducing risk of transmitting infection in endoscopy.$285,503
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Improved cleaning technology for reducing risk of transmitting infection in endoscopy$285,503
Federal grantDepartment of Health and Human Services · Phase II · Improved cleaning technology for reducing risk of transmitting infection in endoscopy.$999,998
Federal grantDepartment of Health and Human Services · Phase II · Improved cleaning technology for reducing risk of transmitting infection in endoscopy.$2,993,069
Federal grantDepartment of Health and Human Services · Phase II · Improved cleaning technology for reducing risk of transmitting infection in endoscopy.$999,998
Federal grantDepartment of Health and Human Services · Phase II · Improved cleaning technology for reducing risk of transmitting infection in endoscopy.$993,073
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
929Telcare, Inc.—$65M
930NeuroSigma, Inc.—$13M
931CymoGen Dx, LLC—$350K
932ADVANCED BIODEVICES LLC——
933VENTRIX INCORPORATED—$5.2M
934Long Bridge Medical, Inc.—$7.2M
935Medical Care Technologies Inc.—$50K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.